Tiemann Investment Advisors’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-4,580
Closed -$370K 194
2022
Q3
$370K Sell
4,580
-50
-1% -$4.49K 0.24% 102
2022
Q2
$416K Sell
4,630
-350
-7% -$35.5K 0.22% 99
2022
Q1
$553K Sell
4,980
-100
-2% -$10.6K 0.26% 84
2021
Q4
$526K Sell
5,080
-50
-1% -$5.79K 0.22% 101
2021
Q3
$643K Sell
5,130
-200
-4% -$25.9K 0.31% 76
2021
Q2
$662K Hold
5,330
0.31% 79
2021
Q1
$630K Buy
5,330
+1,150
+28% +$135K 0.31% 82
2020
Q4
$490K Buy
4,180
+40
+1% +$4.4K 0.26% 94
2020
Q3
$430K Buy
4,140
+685
+20% +$68.8K 0.27% 95
2020
Q2
$317K Buy
3,455
+60
+2% +$5.75K 0.22% 120
2020
Q1
$306K Buy
+3,395
New +$361K 0.27% 94
2015
Q2
Sell
-2,606
Closed -$203K 153
2015
Q1
$203K Buy
+2,606
New +$198K 0.21% 148

Other funds holding MDT

Tiemann Investment Advisors's MDT Position: Q4 2022 in Review

Tiemann Investment Advisors sold out of Medtronic (MDT) in Q4 2022, closing a stake of 4,580 shares — an estimated $370K sold.

Tiemann Investment Advisors first reported a position in MDT in Q1 2015 and held it in 12 quarters. The position peaked at $662K in Q2 2021. 1,961 funds tracked by Wall St. Rank hold MDT as of Q4 2022.

  • Tiemann Investment Advisors reported no remaining Medtronic position as of Q4 2022 after selling out during the quarter.
  • Tiemann Investment Advisors sold 4,580 Medtronic shares in Q4 2022, an estimated $370K.
  • Tiemann Investment Advisors first reported a position in Medtronic in Q1 2015 and held it in 12 quarters.
  • Tiemann Investment Advisors's Medtronic position peaked at $662K in Q2 2021.
  • 1,961 funds tracked by Wall St. Rank held Medtronic as of Q4 2022.

Based on Tiemann Investment Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.